Encompass Health (NYSE:EHC) Stock Price Expected to Rise, KeyCorp Analyst Says

Encompass Health (NYSE:EHC - Free Report) had its price objective increased by KeyCorp from $122.00 to $135.00 in a research note issued to investors on Tuesday morning,Benzinga reports. The firm currently has an overweight rating on the stock.

Other equities analysts also recently issued research reports about the company. UBS Group increased their price target on Encompass Health from $117.00 to $130.00 and gave the stock a "buy" rating in a research report on Monday, April 28th. Barclays boosted their price objective on shares of Encompass Health from $118.00 to $129.00 and gave the stock an "overweight" rating in a research note on Friday, April 25th. William Blair reissued an "outperform" rating on shares of Encompass Health in a research note on Friday, February 7th. Truist Financial reissued a "buy" rating and issued a $135.00 price objective (up previously from $116.00) on shares of Encompass Health in a research note on Monday, April 28th. Finally, Wall Street Zen raised shares of Encompass Health from a "buy" rating to a "strong-buy" rating in a research note on Saturday, May 24th. Eight investment analysts have rated the stock with a buy rating and two have given a strong buy rating to the stock. According to MarketBeat, Encompass Health currently has an average rating of "Buy" and a consensus price target of $122.71.

Encompass Health Trading Up 0.4%

Shares of NYSE EHC traded up $0.47 during trading hours on Tuesday, reaching $119.99. The stock had a trading volume of 552,940 shares, compared to its average volume of 699,372. Encompass Health has a 52-week low of $82.74 and a 52-week high of $121.96. The firm has a market cap of $12.09 billion, a price-to-earnings ratio of 26.90, a P/E/G ratio of 2.31 and a beta of 0.91. The business's fifty day moving average price is $109.12 and its two-hundred day moving average price is $101.77. The company has a current ratio of 1.05, a quick ratio of 1.04 and a debt-to-equity ratio of 0.84.

Encompass Health (NYSE:EHC - Get Free Report) last posted its quarterly earnings results on Thursday, April 24th. The company reported $1.37 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $1.19 by $0.18. Encompass Health had a return on equity of 17.56% and a net margin of 8.48%. The business had revenue of $1.46 billion for the quarter, compared to the consensus estimate of $1.43 billion. During the same quarter in the prior year, the company earned $1.12 EPS. The business's revenue was up 10.6% compared to the same quarter last year. Analysts expect that Encompass Health will post 4.8 EPS for the current fiscal year.

Encompass Health Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Tuesday, July 15th. Stockholders of record on Tuesday, July 1st will be given a dividend of $0.17 per share. This represents a $0.68 dividend on an annualized basis and a dividend yield of 0.57%. The ex-dividend date of this dividend is Tuesday, July 1st. Encompass Health's payout ratio is presently 14.05%.

Insider Activity at Encompass Health

In related news, insider Elissa Joy Charbonneau sold 4,279 shares of the company's stock in a transaction on Tuesday, May 6th. The stock was sold at an average price of $116.61, for a total value of $498,974.19. Following the transaction, the insider now directly owns 11,958 shares of the company's stock, valued at $1,394,422.38. This represents a 26.35% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, CEO Mark J. Tarr sold 118,384 shares of the company's stock in a transaction on Tuesday, May 20th. The shares were sold at an average price of $121.53, for a total value of $14,387,207.52. Following the completion of the transaction, the chief executive officer now directly owns 527,070 shares in the company, valued at approximately $64,054,817.10. The trade was a 18.34% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold a total of 132,663 shares of company stock valued at $16,034,082 in the last ninety days. Company insiders own 2.00% of the company's stock.

Institutional Investors Weigh In On Encompass Health

Hedge funds have recently added to or reduced their stakes in the business. Charles Schwab Investment Management Inc. boosted its holdings in Encompass Health by 0.7% in the fourth quarter. Charles Schwab Investment Management Inc. now owns 644,764 shares of the company's stock valued at $59,544,000 after purchasing an additional 4,345 shares during the last quarter. BI Asset Management Fondsmaeglerselskab A S purchased a new stake in Encompass Health in the fourth quarter valued at $4,160,000. US Bancorp DE boosted its holdings in Encompass Health by 9.6% in the fourth quarter. US Bancorp DE now owns 1,380 shares of the company's stock valued at $127,000 after purchasing an additional 121 shares during the last quarter. New York State Teachers Retirement System boosted its holdings in Encompass Health by 0.3% in the fourth quarter. New York State Teachers Retirement System now owns 76,102 shares of the company's stock valued at $7,028,000 after purchasing an additional 200 shares during the last quarter. Finally, Farallon Capital Management LLC boosted its holdings in Encompass Health by 15,266.7% in the fourth quarter. Farallon Capital Management LLC now owns 461,000 shares of the company's stock valued at $42,573,000 after purchasing an additional 458,000 shares during the last quarter. 97.25% of the stock is owned by hedge funds and other institutional investors.

About Encompass Health

Encompass Health Corporation provides post-acute healthcare services in the United States and Puerto Rico. It owns and operates inpatient rehabilitation hospitals that provide medical, nursing, therapy, and ancillary services. The company provides specialized rehabilitative treatment on an inpatient basis to patients who have experienced physical or cognitive disabilities or injuries due to medical conditions, such as strokes, hip fractures, and various debilitating neurological conditions.